echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tasly Launches Phase III Study of Compound Danshen Dripping Pills in the Treatment of Acute Altitude Sickness in the United States

    Tasly Launches Phase III Study of Compound Danshen Dripping Pills in the Treatment of Acute Altitude Sickness in the United States

    • Last Update: 2021-09-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Article source: Medical Rubik's Cube Info

    Recently, Tasly registered a Phase III clinical study on the prevention and treatment of acute altitude sickness (AMS) with T89 (Compound Danshen Dripping Pills) on the American Clinical Network


    According to Tasly’s announcement, the prevention and treatment of acute altitude sickness (AMS) is a new indication discovered in many real-world clinical observations of T89


    The compound Danshen dripping pill is a modern and innovative Chinese compound medicine developed exclusively by Tasly, which is mainly used for the prevention and treatment of cardiovascular diseases.


    After that, Tasly submitted the new drug application (NDA) related approval information for T89 treatment of CSA to the FDA, and held a meeting with the FDA


    Acute altitude sickness (AMS) is a common hypoxic disease that is unique to altitude.


    T89 is the world's first Chinese compound medicine to apply for new drug listing in the United States


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.